JPMorgan Downgrades Ethos Technologies Stock to Neutral

JPMorgan downgraded Ethos Technologies (NASDAQ:LIFE) to neutral from overweight, setting a price target of $37.00 according to a report from Investing.com. The rating change reflects a balanced risk-reward profile following a sharp stock rally, alongside concerns regarding lower cash flow conversion.

"JPMorgan downgrades Ethos Technologies stock rating to neutral," according to Investing.com.

Financial Performance and Guidance

The analyst adjustment follows a strong period of reported financial growth for the company. In its second-quarter earnings report for 2026, Ethos posted revenue of $189.6 million, marking a 113% increase compared to the same period in the previous year.

Alongside the revenue growth, Ethos reported earnings per share of $0.53. Based on the quarterly performance, management raised its full-year 2026 revenue guidance to a range of $727 million to $731 million.

Insider Stock Sales

The downgrade also coincides with recent insider transactions executed under pre-arranged Rule 10b5-1 trading plans. According to MarketBeat data, President Lingke Wang sold 118,333 shares on Thursday, September 17th, at an average price of $38.96.

Additionally, CEO Peter Colis sold 23,333 shares on the same day at an average price of $38.85. Rule 10b5-1 plans allow corporate insiders to set up a predetermined schedule for selling stocks at a time when they are not in possession of material non-public information, helping to avoid potential insider trading concerns.

What is at Stake for Investors

For market participants following Ethos Technologies, the JPMorgan downgrade highlights the tension between rapid top-line expansion and valuation multiples. While the firm has accelerated its revenue past the $180 million quarterly mark and raised forward guidance, analysts are weighing whether the recent equity rally fully prices in the underlying cash flow dynamics.